Skip to main content

Yang (Cindy) Cao

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Yang (Cindy) Cao

Humacyte, Inc. reported in an 8-K filed September 20, 2022 that Yang (Cindy) Cao was appointed Chief Regulatory Officer.

“pharma industry veteran Yang (Cindy) Cao, Ph.D. joins as the Company’s Chief Regulatory Officer.”
Humacyte, Inc. Form 8-K, filed September 20, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Humacyte, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.